Prevention of Oral Mucositis in Adults in With Hematologic Malignancy | MicrobiomeTrials← Back to trialsNCT07809984
Prevention of Oral Mucositis in Adults in With Hematologic Malignancy
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-10Est. Completion: 2028-12
Enrollment target: 206 participants Locations- Advocate Christ Medical Center, Oak Lawn, Illinois, United States
- Advocate Lutheran General, Park Ridge, Illinois, United States
- Aurora St. Luke's Medical Center, Milwaukee, Wisconsin, United States
Other microbiome trials you might be interested in
Acute Myeloid LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative NeoplasmAcute Myeloid Leukemia Post Cytotoxic TherapyAcute Myeloid Leukemia, Myelodysplasia-RelatedMyelodysplastic Syndrome
This MyeloMATCH Master Screening and Reassessment Protocol (MSRP) evaluates the use of a screening tool and specific lab…
Birmingham, United StatesEst. completion May 15, 2029
Acute Lymphoblastic Leukemia, Pediatric
The study aims to conduct a real-world investigation of children with Philadelphia chromosome-positive acute lymphoblast…
Hangzhou, ChinaEst. completion Sep 2026
Acute LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAcute Biphenotypic LeukemiaAcute Undifferentiated LeukemiaCLL (Chronic Lymphocytic Leukemia)Chronic Myeloid Leukemia (CML)MDS (Myelodysplastic Syndrome)Non-Hodgkin LymphomasHodgkins LymphomaCutaneous T Cell Lymphomas (CTCL)
The goal of this clinical trial is to determine the safety and feasibility of allogeneic transplantation with bone marro…
Duarte, United StatesEst. completion Jul 14, 2026